About this article Cite this article St-Pierre, J., Klein, J., Choi, N.K
Invokana (canagliflozin) Invokana (canagliflozin), an SGLT2 inhibitor, is now a first-line option for Type 2 diabetes patients with cardiovascular disease, high cardiovascular risk, heart failure, or chronic kidney disease (CKD), regardless of baseline A1C, according to the 2022 American Diabetes Association (ADA) Standards of Care in Diabetes
For instance, Novo Nordisk is seeking to enroll 2,500 people for a study of how its brand-name GLP-1 medication, Wegovy, is being used in the real world
What is the best skincare routine for tan removal on the body
To get the most benefit from GLP-1 medications and manage side effects effectively, it is best to combine them with an intentional diet, regular exercise, and mindful habits
Polyphenols: nutraceutical approach towards chronic fatigue Polyphenols are one of the most potent antioxidant phytochemicals, whose antioxidant effects are attributed to their ability to increase antioxidant defenses
